Skip to main content
. 2016 Sep 16;7(43):70546–70558. doi: 10.18632/oncotarget.12060
CKAP4 A forward 5′-CAACACAACCCGAACTCAGC-3′
CKAP4 A reverse 5′-CTTTGGGGGCAGAAAGACCT-3′
CKAP4 B forward 5′-CAAGGTCTTTCTGCCCCCAAAG-3′
CKAP4 B reverse 5′-AAGCAACTTGCCCACTCACT-3′
PSEN2 A forward 5′-CCAAATCCTGGAACCACA-3′
PSEN2 A reverse 5′-GTCGGAACTAAGCGACGACC-3′
PSEN2 B forward 5′-CTCAACCTACCCCACAGACC-3′
PSEN2 B reverse 5′-GGCGGTAGGACATAGGCTTCG-3′
KEAP1 A forward 5′-AATTTTCCCTAGATCCTGCGGC-3′
KEAP1 A reverse 5′-GAAAGGAGCGGCGATTCTC-3′
KEAP1 B forward 5′-GATCGCTTGAGGCCAGGAGC-3′
KEAP1 B reverse 5′- GAAAGGAGCGGCGATTCTC-3′